NMPA/PMDA News
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Navigate NMPA & PMDA drug approvals, regulatory updates, and market access strategies. Stay ahead in China & Japan pharma with critical intelligence.
Showing 1–3 of 3 articles
Quick answer
NovaPharmaNews NMPA/PMDA News hub for FDA covers 3 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Roche Expands Alecensa Approval in Japan: Implications for Pharma
Amgen's Commitment to Tavneos Amid Concerns in Japan
GSK's Depemokimab Receives European and Chinese Approvals, Expanding Global Access to Ultra-Long-Acting Biologic
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.